nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0324	0.0428	CbGbCtD
Modafinil—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0305	0.0402	CbGbCtD
Modafinil—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0305	0.0402	CbGbCtD
Modafinil—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0276	0.0364	CbGbCtD
Modafinil—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.024	0.0317	CbGbCtD
Modafinil—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0231	0.0305	CbGbCtD
Modafinil—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0217	0.0287	CbGbCtD
Modafinil—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0217	0.0287	CbGbCtD
Modafinil—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0209	0.0276	CbGbCtD
Modafinil—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0206	0.0272	CbGbCtD
Modafinil—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0194	0.0256	CbGbCtD
Modafinil—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.019	0.0251	CbGbCtD
Modafinil—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0188	0.0247	CbGbCtD
Modafinil—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0182	0.024	CbGbCtD
Modafinil—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0179	0.0236	CbGbCtD
Modafinil—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0179	0.0236	CbGbCtD
Modafinil—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0175	0.0231	CbGbCtD
Modafinil—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0231	CbGbCtD
Modafinil—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0171	0.0226	CbGbCtD
Modafinil—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0165	0.0217	CbGbCtD
Modafinil—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0165	0.0217	CbGbCtD
Modafinil—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0162	0.0213	CbGbCtD
Modafinil—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0161	0.0212	CbGbCtD
Modafinil—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0161	0.0212	CbGbCtD
Modafinil—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0199	CbGbCtD
Modafinil—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0147	0.0194	CbGbCtD
Modafinil—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0146	0.0192	CbGbCtD
Modafinil—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0146	0.0192	CbGbCtD
Modafinil—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0135	0.0179	CbGbCtD
Modafinil—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0133	0.0175	CbGbCtD
Modafinil—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0133	0.0175	CbGbCtD
Modafinil—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0127	0.0168	CbGbCtD
Modafinil—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0126	0.0166	CbGbCtD
Modafinil—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0123	0.0162	CbGbCtD
Modafinil—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0122	0.0161	CbGbCtD
Modafinil—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.011	0.0146	CbGbCtD
Modafinil—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.011	0.0146	CbGbCtD
Modafinil—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0106	0.014	CbGbCtD
Modafinil—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00996	0.0131	CbGbCtD
Modafinil—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00937	0.0124	CbGbCtD
Modafinil—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00937	0.0124	CbGbCtD
Modafinil—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00847	0.0112	CbGbCtD
Modafinil—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00847	0.0112	CbGbCtD
Modafinil—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00731	0.00964	CbGbCtD
Modafinil—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0071	0.00936	CbGbCtD
Modafinil—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00642	0.00847	CbGbCtD
Modafinil—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00642	0.00847	CbGbCtD
Modafinil—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00615	0.00812	CbGbCtD
Modafinil—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00204	0.104	CbGeAlD
Modafinil—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00117	0.0597	CbGeAlD
Modafinil—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000959	0.0488	CbGeAlD
Modafinil—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000925	0.047	CbGeAlD
Modafinil—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000919	0.0468	CbGeAlD
Modafinil—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00091	0.0463	CbGeAlD
Modafinil—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000694	0.0353	CbGeAlD
Modafinil—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000614	0.0312	CbGeAlD
Modafinil—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000591	0.0301	CbGeAlD
Modafinil—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.000546	0.0278	CbGeAlD
Modafinil—SLC6A3—lung—acquired immunodeficiency syndrome	0.000497	0.0253	CbGeAlD
Modafinil—ADRA1B—brain—acquired immunodeficiency syndrome	0.000469	0.0239	CbGeAlD
Modafinil—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.00046	0.0234	CbGeAlD
Modafinil—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000451	0.023	CbGeAlD
Modafinil—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000443	0.0225	CbGeAlD
Modafinil—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000442	0.0225	CbGeAlD
Modafinil—CYP2C19—blood—acquired immunodeficiency syndrome	0.00043	0.0219	CbGeAlD
Modafinil—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000399	0.0203	CbGeAlD
Modafinil—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000369	0.0188	CbGeAlD
Modafinil—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000358	0.0182	CbGeAlD
Modafinil—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000356	0.0181	CbGeAlD
Modafinil—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000353	0.018	CbGeAlD
Modafinil—SLC6A3—brain—acquired immunodeficiency syndrome	0.000351	0.0179	CbGeAlD
Modafinil—CYP1A2—blood—acquired immunodeficiency syndrome	0.000351	0.0179	CbGeAlD
Modafinil—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.00035	0.0178	CbGeAlD
Modafinil—CYP3A5—blood—acquired immunodeficiency syndrome	0.000339	0.0172	CbGeAlD
Modafinil—CYP2B6—blood—acquired immunodeficiency syndrome	0.000337	0.0171	CbGeAlD
Modafinil—CYP2C9—blood—acquired immunodeficiency syndrome	0.000333	0.017	CbGeAlD
Modafinil—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000314	0.016	CbGeAlD
Modafinil—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000312	0.0159	CbGeAlD
Modafinil—CYP1A2—lung—acquired immunodeficiency syndrome	0.000308	0.0157	CbGeAlD
Modafinil—CYP3A5—lung—acquired immunodeficiency syndrome	0.000297	0.0151	CbGeAlD
Modafinil—CYP2B6—lung—acquired immunodeficiency syndrome	0.000295	0.015	CbGeAlD
Modafinil—Fosphenytoin—ALB—acquired immunodeficiency syndrome	0.000276	0.214	CrCbGaD
Modafinil—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000273	0.0139	CbGeAlD
Modafinil—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000267	0.0136	CbGeAlD
Modafinil—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000263	0.0134	CbGeAlD
Modafinil—CYP3A4—blood—acquired immunodeficiency syndrome	0.000254	0.0129	CbGeAlD
Modafinil—Fenoprofen—ALB—acquired immunodeficiency syndrome	0.00022	0.17	CrCbGaD
Modafinil—CYP2B6—brain—acquired immunodeficiency syndrome	0.000209	0.0106	CbGeAlD
Modafinil—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000206	0.0105	CbGeAlD
Modafinil—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000199	0.0101	CbGeAlD
Modafinil—Phenprocoumon—ALB—acquired immunodeficiency syndrome	0.000189	0.147	CrCbGaD
Modafinil—Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.000184	0.143	CrCbGaD
Modafinil—Warfarin—ALB—acquired immunodeficiency syndrome	0.000168	0.13	CrCbGaD
Modafinil—Ketoprofen—ALB—acquired immunodeficiency syndrome	0.00013	0.101	CrCbGaD
Modafinil—Phenytoin—ALB—acquired immunodeficiency syndrome	0.000122	0.0946	CrCbGaD
Modafinil—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000532	CcSEcCtD
Modafinil—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000532	CcSEcCtD
Modafinil—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000532	CcSEcCtD
Modafinil—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000531	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00053	CcSEcCtD
Modafinil—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000529	CcSEcCtD
Modafinil—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000117	0.000528	CcSEcCtD
Modafinil—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000528	CcSEcCtD
Modafinil—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000528	CcSEcCtD
Modafinil—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000528	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000527	CcSEcCtD
Modafinil—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000527	CcSEcCtD
Modafinil—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000526	CcSEcCtD
Modafinil—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000524	CcSEcCtD
Modafinil—Pain—Indinavir—acquired immunodeficiency syndrome	0.000116	0.000524	CcSEcCtD
Modafinil—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000523	CcSEcCtD
Modafinil—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000523	CcSEcCtD
Modafinil—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000523	CcSEcCtD
Modafinil—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000522	CcSEcCtD
Modafinil—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000521	CcSEcCtD
Modafinil—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000521	CcSEcCtD
Modafinil—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000521	CcSEcCtD
Modafinil—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000115	0.00052	CcSEcCtD
Modafinil—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000115	0.00052	CcSEcCtD
Modafinil—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000519	CcSEcCtD
Modafinil—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000114	0.000518	CcSEcCtD
Modafinil—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000114	0.000518	CcSEcCtD
Modafinil—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000517	CcSEcCtD
Modafinil—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000517	CcSEcCtD
Modafinil—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000517	CcSEcCtD
Modafinil—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000516	CcSEcCtD
Modafinil—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000516	CcSEcCtD
Modafinil—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000514	CcSEcCtD
Modafinil—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000514	CcSEcCtD
Modafinil—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000514	CcSEcCtD
Modafinil—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000514	CcSEcCtD
Modafinil—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000512	CcSEcCtD
Modafinil—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000512	CcSEcCtD
Modafinil—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000113	0.000511	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.00051	CcSEcCtD
Modafinil—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000509	CcSEcCtD
Modafinil—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000508	CcSEcCtD
Modafinil—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000506	CcSEcCtD
Modafinil—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000505	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000504	CcSEcCtD
Modafinil—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000504	CcSEcCtD
Modafinil—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000503	CcSEcCtD
Modafinil—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000503	CcSEcCtD
Modafinil—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000503	CcSEcCtD
Modafinil—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000111	0.000503	CcSEcCtD
Modafinil—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000502	CcSEcCtD
Modafinil—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000111	0.000501	CcSEcCtD
Modafinil—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000501	CcSEcCtD
Modafinil—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000501	CcSEcCtD
Modafinil—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.0005	CcSEcCtD
Modafinil—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.0005	CcSEcCtD
Modafinil—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000499	CcSEcCtD
Modafinil—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00011	0.000499	CcSEcCtD
Modafinil—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000499	CcSEcCtD
Modafinil—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000497	CcSEcCtD
Modafinil—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00011	0.000497	CcSEcCtD
Modafinil—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000497	CcSEcCtD
Modafinil—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000495	CcSEcCtD
Modafinil—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000495	CcSEcCtD
Modafinil—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000495	CcSEcCtD
Modafinil—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000495	CcSEcCtD
Modafinil—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000494	CcSEcCtD
Modafinil—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000494	CcSEcCtD
Modafinil—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000109	0.000494	CcSEcCtD
Modafinil—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000493	CcSEcCtD
Modafinil—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000492	CcSEcCtD
Modafinil—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000109	0.000492	CcSEcCtD
Modafinil—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00049	CcSEcCtD
Modafinil—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00049	CcSEcCtD
Modafinil—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.00049	CcSEcCtD
Modafinil—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.00049	CcSEcCtD
Modafinil—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000489	CcSEcCtD
Modafinil—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000488	CcSEcCtD
Modafinil—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000487	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000487	CcSEcCtD
Modafinil—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000487	CcSEcCtD
Modafinil—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000485	CcSEcCtD
Modafinil—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000484	CcSEcCtD
Modafinil—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000484	CcSEcCtD
Modafinil—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000484	CcSEcCtD
Modafinil—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000483	CcSEcCtD
Modafinil—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000107	0.000483	CcSEcCtD
Modafinil—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000106	0.000482	CcSEcCtD
Modafinil—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000481	CcSEcCtD
Modafinil—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00048	CcSEcCtD
Modafinil—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000479	CcSEcCtD
Modafinil—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000479	CcSEcCtD
Modafinil—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000479	CcSEcCtD
Modafinil—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000478	CcSEcCtD
Modafinil—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000478	CcSEcCtD
Modafinil—Rash—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000478	CcSEcCtD
Modafinil—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000477	CcSEcCtD
Modafinil—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000477	CcSEcCtD
Modafinil—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000477	CcSEcCtD
Modafinil—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000476	CcSEcCtD
Modafinil—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000105	0.000476	CcSEcCtD
Modafinil—Headache—Stavudine—acquired immunodeficiency syndrome	0.000105	0.000475	CcSEcCtD
Modafinil—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000105	0.000475	CcSEcCtD
Modafinil—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000474	CcSEcCtD
Modafinil—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000473	CcSEcCtD
Modafinil—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000105	0.000473	CcSEcCtD
Modafinil—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000473	CcSEcCtD
Modafinil—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000472	CcSEcCtD
Modafinil—Rash—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000471	CcSEcCtD
Modafinil—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000104	0.00047	CcSEcCtD
Modafinil—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00047	CcSEcCtD
Modafinil—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.00047	CcSEcCtD
Modafinil—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.00047	CcSEcCtD
Modafinil—Headache—Abacavir—acquired immunodeficiency syndrome	0.000103	0.000468	CcSEcCtD
Modafinil—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000467	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000466	CcSEcCtD
Modafinil—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000103	0.000466	CcSEcCtD
Modafinil—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000103	0.000466	CcSEcCtD
Modafinil—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000463	CcSEcCtD
Modafinil—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000462	CcSEcCtD
Modafinil—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000461	CcSEcCtD
Modafinil—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.00046	CcSEcCtD
Modafinil—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.00046	CcSEcCtD
Modafinil—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.00046	CcSEcCtD
Modafinil—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000457	CcSEcCtD
Modafinil—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000457	CcSEcCtD
Modafinil—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000457	CcSEcCtD
Modafinil—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000456	CcSEcCtD
Modafinil—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000456	CcSEcCtD
Modafinil—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000455	CcSEcCtD
Modafinil—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000454	CcSEcCtD
Modafinil—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000453	CcSEcCtD
Modafinil—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.97e-05	0.000451	CcSEcCtD
Modafinil—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.96e-05	0.000451	CcSEcCtD
Modafinil—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.95e-05	0.000451	CcSEcCtD
Modafinil—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.95e-05	0.000451	CcSEcCtD
Modafinil—Nausea—Stavudine—acquired immunodeficiency syndrome	9.94e-05	0.00045	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000449	CcSEcCtD
Modafinil—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.9e-05	0.000448	CcSEcCtD
Modafinil—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.84e-05	0.000446	CcSEcCtD
Modafinil—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.83e-05	0.000445	CcSEcCtD
Modafinil—Nausea—Abacavir—acquired immunodeficiency syndrome	9.79e-05	0.000443	CcSEcCtD
Modafinil—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.77e-05	0.000442	CcSEcCtD
Modafinil—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.76e-05	0.000442	CcSEcCtD
Modafinil—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.75e-05	0.000441	CcSEcCtD
Modafinil—Urticaria—Delavirdine—acquired immunodeficiency syndrome	9.71e-05	0.00044	CcSEcCtD
Modafinil—Asthenia—Indinavir—acquired immunodeficiency syndrome	9.7e-05	0.000439	CcSEcCtD
Modafinil—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	9.7e-05	0.000439	CcSEcCtD
Modafinil—Hypotension—Lamivudine—acquired immunodeficiency syndrome	9.7e-05	0.000439	CcSEcCtD
Modafinil—Somnolence—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000438	CcSEcCtD
Modafinil—Pain—Ritonavir—acquired immunodeficiency syndrome	9.67e-05	0.000438	CcSEcCtD
Modafinil—Constipation—Ritonavir—acquired immunodeficiency syndrome	9.67e-05	0.000438	CcSEcCtD
Modafinil—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	9.67e-05	0.000438	CcSEcCtD
Modafinil—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	9.67e-05	0.000438	CcSEcCtD
Modafinil—Dizziness—Zidovudine—acquired immunodeficiency syndrome	9.62e-05	0.000435	CcSEcCtD
Modafinil—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	9.58e-05	0.000434	CcSEcCtD
Modafinil—Pruritus—Indinavir—acquired immunodeficiency syndrome	9.57e-05	0.000433	CcSEcCtD
Modafinil—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	9.46e-05	0.000428	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000428	CcSEcCtD
Modafinil—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	9.41e-05	0.000426	CcSEcCtD
Modafinil—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000425	CcSEcCtD
Modafinil—Insomnia—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.000425	CcSEcCtD
Modafinil—Fatigue—Saquinavir—acquired immunodeficiency syndrome	9.38e-05	0.000425	CcSEcCtD
Modafinil—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	9.32e-05	0.000422	CcSEcCtD
Modafinil—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000422	CcSEcCtD
Modafinil—Pain—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000421	CcSEcCtD
Modafinil—Constipation—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000421	CcSEcCtD
Modafinil—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	9.26e-05	0.000419	CcSEcCtD
Modafinil—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	9.25e-05	0.000419	CcSEcCtD
Modafinil—Vomiting—Zidovudine—acquired immunodeficiency syndrome	9.25e-05	0.000419	CcSEcCtD
Modafinil—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	9.25e-05	0.000419	CcSEcCtD
Modafinil—Somnolence—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000418	CcSEcCtD
Modafinil—Rash—Zidovudine—acquired immunodeficiency syndrome	9.17e-05	0.000415	CcSEcCtD
Modafinil—Asthenia—Efavirenz—acquired immunodeficiency syndrome	9.17e-05	0.000415	CcSEcCtD
Modafinil—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	9.16e-05	0.000415	CcSEcCtD
Modafinil—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	9.14e-05	0.000414	CcSEcCtD
Modafinil—Headache—Zidovudine—acquired immunodeficiency syndrome	9.11e-05	0.000413	CcSEcCtD
Modafinil—Pruritus—Efavirenz—acquired immunodeficiency syndrome	9.04e-05	0.000409	CcSEcCtD
Modafinil—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.02e-05	0.000409	CcSEcCtD
Modafinil—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.01e-05	0.000408	CcSEcCtD
Modafinil—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.98e-05	0.000407	CcSEcCtD
Modafinil—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000406	CcSEcCtD
Modafinil—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000406	CcSEcCtD
Modafinil—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.95e-05	0.000405	CcSEcCtD
Modafinil—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.94e-05	0.000405	CcSEcCtD
Modafinil—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000405	CcSEcCtD
Modafinil—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000405	CcSEcCtD
Modafinil—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.9e-05	0.000403	CcSEcCtD
Modafinil—Pain—Lamivudine—acquired immunodeficiency syndrome	8.88e-05	0.000402	CcSEcCtD
Modafinil—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.88e-05	0.000402	CcSEcCtD
Modafinil—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.77e-05	0.000397	CcSEcCtD
Modafinil—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.74e-05	0.000396	CcSEcCtD
Modafinil—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8.65e-05	0.000392	CcSEcCtD
Modafinil—Urticaria—Saquinavir—acquired immunodeficiency syndrome	8.65e-05	0.000391	CcSEcCtD
Modafinil—Nausea—Zidovudine—acquired immunodeficiency syndrome	8.64e-05	0.000391	CcSEcCtD
Modafinil—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.00039	CcSEcCtD
Modafinil—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.00039	CcSEcCtD
Modafinil—Vomiting—Indinavir—acquired immunodeficiency syndrome	8.6e-05	0.000389	CcSEcCtD
Modafinil—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000387	CcSEcCtD
Modafinil—Rash—Indinavir—acquired immunodeficiency syndrome	8.53e-05	0.000386	CcSEcCtD
Modafinil—Dermatitis—Indinavir—acquired immunodeficiency syndrome	8.52e-05	0.000386	CcSEcCtD
Modafinil—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	8.49e-05	0.000384	CcSEcCtD
Modafinil—Headache—Indinavir—acquired immunodeficiency syndrome	8.47e-05	0.000384	CcSEcCtD
Modafinil—Dizziness—Efavirenz—acquired immunodeficiency syndrome	8.45e-05	0.000383	CcSEcCtD
Modafinil—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	8.37e-05	0.000379	CcSEcCtD
Modafinil—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	8.33e-05	0.000377	CcSEcCtD
Modafinil—Urticaria—Lamivudine—acquired immunodeficiency syndrome	8.25e-05	0.000373	CcSEcCtD
Modafinil—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000372	CcSEcCtD
Modafinil—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000372	CcSEcCtD
Modafinil—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.12e-05	0.000368	CcSEcCtD
Modafinil—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.11e-05	0.000367	CcSEcCtD
Modafinil—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.09e-05	0.000366	CcSEcCtD
Modafinil—Rash—Efavirenz—acquired immunodeficiency syndrome	8.06e-05	0.000365	CcSEcCtD
Modafinil—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.05e-05	0.000364	CcSEcCtD
Modafinil—Nausea—Indinavir—acquired immunodeficiency syndrome	8.03e-05	0.000364	CcSEcCtD
Modafinil—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.02e-05	0.000363	CcSEcCtD
Modafinil—Headache—Efavirenz—acquired immunodeficiency syndrome	8.01e-05	0.000362	CcSEcCtD
Modafinil—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8e-05	0.000362	CcSEcCtD
Modafinil—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000354	CcSEcCtD
Modafinil—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.77e-05	0.000352	CcSEcCtD
Modafinil—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.00035	CcSEcCtD
Modafinil—Rash—Delavirdine—acquired immunodeficiency syndrome	7.71e-05	0.000349	CcSEcCtD
Modafinil—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.7e-05	0.000349	CcSEcCtD
Modafinil—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.7e-05	0.000349	CcSEcCtD
Modafinil—Headache—Delavirdine—acquired immunodeficiency syndrome	7.66e-05	0.000347	CcSEcCtD
Modafinil—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.65e-05	0.000346	CcSEcCtD
Modafinil—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.59e-05	0.000344	CcSEcCtD
Modafinil—Dizziness—Ritonavir—acquired immunodeficiency syndrome	7.48e-05	0.000339	CcSEcCtD
Modafinil—Asthenia—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000337	CcSEcCtD
Modafinil—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000337	CcSEcCtD
Modafinil—Pruritus—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000333	CcSEcCtD
Modafinil—Nausea—Delavirdine—acquired immunodeficiency syndrome	7.26e-05	0.000329	CcSEcCtD
Modafinil—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.2e-05	0.000326	CcSEcCtD
Modafinil—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.19e-05	0.000326	CcSEcCtD
Modafinil—Rash—Ritonavir—acquired immunodeficiency syndrome	7.13e-05	0.000323	CcSEcCtD
Modafinil—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.12e-05	0.000323	CcSEcCtD
Modafinil—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.1e-05	0.000322	CcSEcCtD
Modafinil—Headache—Ritonavir—acquired immunodeficiency syndrome	7.08e-05	0.000321	CcSEcCtD
Modafinil—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.92e-05	0.000313	CcSEcCtD
Modafinil—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000311	CcSEcCtD
Modafinil—Rash—Saquinavir—acquired immunodeficiency syndrome	6.86e-05	0.000311	CcSEcCtD
Modafinil—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.86e-05	0.00031	CcSEcCtD
Modafinil—Headache—Saquinavir—acquired immunodeficiency syndrome	6.82e-05	0.000309	CcSEcCtD
Modafinil—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.72e-05	0.000304	CcSEcCtD
Modafinil—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.6e-05	0.000299	CcSEcCtD
Modafinil—Rash—Lamivudine—acquired immunodeficiency syndrome	6.55e-05	0.000296	CcSEcCtD
Modafinil—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000296	CcSEcCtD
Modafinil—Headache—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.000294	CcSEcCtD
Modafinil—Nausea—Saquinavir—acquired immunodeficiency syndrome	6.46e-05	0.000293	CcSEcCtD
Modafinil—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.17e-05	0.000279	CcSEcCtD
